NCT05978063 - Study to Evaluate the Efficacy and Safety of Oral Difelikefalin for Moderate to Severe Pruritus in Subjects With Notalgia Paresthetica | Biotech Hunter

Enrollment

214

Participants

Timeline

Start Date

August 1, 2023

Primary Completion Date

April 22, 2024

Study Completion Date

May 7, 2024

Conditions

PruritusNotalgia Paresthetica

Interventions

DRUG

difelikefalin 2.0 mg tablets

Oral difelikefalin 2.0 mg administered twice daily

DRUG

difelikefalin 1.0 mg tablets

Oral difelikefalin 1.0 mg administered twice daily

DRUG

difelikefalin 0.25 mg tablets

Oral difelikefalin 0.25 mg administered twice daily

DRUG

Placebo tablets

Oral Placebo administered twice daily

Trial Locations (58)

15213

Cara Therapeutics Study Site, Pittsburgh

20850

Cara Therapeutics Study Site, Rockville

29425

Cara Therapeutics Study Site, Charleston

33021

Cara Therapeutics Study Site, Hollywood

33063

Cara Therapeutics Study Site, Margate

33134

Cara Therapeutics Study Site, Coral Gables

33558

Cara Therapeutics Study Site, Lutz

33607

Cara Therapeutics Study Site, Tampa

35244

Cara Therapeutics Study Site, Birmingham

37179

Cara Therapeutics Study Site, Thompson's Station

44512

Cara Therapeutics Study Site, Boardman

45040

Cara Therapeutics Study Site, Mason

46168

Cara Therapeutics Study Site, Plainfield

46250

Cara Therapeutics Study Site, Indianapolis

47906

Cara Therapeutics Study Site, West Lafayette

48059

Cara Therapeutics Study Site, Fort Gratiot

58103

Cara Therapeutics Study Site, Fargo

70006

Cara Therapeutics Study Site, Metairie

70115

Cara Therapeutics Study Site, New Orleans

70808

Cara Therapeutics Study Site, Baton Rouge

70809

Cara Therapeutics Study Site, Baton Rouge

71913

Cara Therapeutics Study Site, Hot Springs

72703

Cara Therapeutics Study Site, Fayetteville

75230

Cara Therapeutics Study Site, Dallas

77056

Cara Therapeutics Study Site, Houston

77598

Cara Therapeutics Study Site, Webster

78213

Cara Therapeutics Study Site, San Antonio

78660

Cara Therapeutics Study Site, Pflugerville

85032

Cara Therapeutics Study Site, Phoenix

89509

Cara Therapeutics Study Site, Reno

90045

Cara Therapeutics Study Site, Los Angeles

91324

Cara Therapeutics Study Site, Northridge

91355

Cara Therapeutics Study Site, Valencia

91436

Cara Therapeutics Study Site, Encino

92708

Cara Therapeutics Study Site, Fountain Valley

99202

Cara Therapeutics Study Site, Spokane

03801

Cara Therapeutics Study Site, Portsmouth

07044

Cara Therapeutics Study Site, Verona

Unknown

Cara Therapeutics Study Site, Oakville

Cara Therapeutics Study Site, Peterborough

Cara Therapeutics Study Site, Richmond Hill

Cara Therapeutics Study Site, Toronto

Cara Therapeutics Study Site, Sherbrooke

Cara Therapeutics Study Site, Montreal

Cara Therapeutics Study Site, Oshawa

Cara Therapeutics Study Site, Québec

Cara Therapeutics Study Site, Bad Bentheim

Cara Therapeutics Study Site, Berlin

Cara Therapeutics Study Site, Heidelberg

Cara Therapeutics Study Site 2, Langenau

Cara Therapeutics Study Site, Langenau

Cara Therapeutics Study Site 2, Katowice

Cara Therapeutics Study Site, Katowice

Cara Therapeutics Study Site, Sosnowiec

Cara Therapeutics Study Site, Szczecin

Cara Therapeutics Study Site, Wroclaw

Cara Therapeutics Study Site, Bilbao

Cara Therapeutics Study Site, Madrid